We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including Axunio UK and Pierre Fabre Ltd. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Event Schedule

Tuesday, May 19, 2026
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Hypertension updates: from guidelines to consultation
  • Accurate diagnosis and monitoring: ambulatory vs home vs clinic measurements
  • Risk stratification and individualised treatment pathways
  • Managing resistant hypertension and common comorbidities
  • Lifestyle interventions and adherence strategies that work in everyday practice
 
10:40 AM - 11:25 AM
Sponsored session to be confirmed (Diabetes)
 
 
11:40 AM - 12:25 PM
Sponsored session to be confirmed (Weight management)
 
 
12:40 PM - 1:25 PM
CKD clinical conundrums
  • Evidence
  • Risk stratification
  • Kidney protective therapies
 
1:40 PM - 2:25 PM
Sponsored session to be confirmed (Insomnia)
 
 
2:40 PM - 3:25 PM
An overview of cryotherapy/cryosurgery treatments in primary care for the removal of benign skin lesions
 
 
3:40 PM - 4:25 PM
Management of type 2 diabetes: the NICE way to do it
  • Understand NICE's approach to managing Type 2 diabetes
  • Recognise how treatment choices are tailored based on comorbidities , hypoglycemia risk , weight and age 
  • The importance of ongoing monitoring and complication prevention 
 
4:30 PM
Conference ends
 
 
Wednesday, May 20, 2026
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Practical use of emollients in chronic skin disease management
 
 
10:40 AM - 11:25 AM
Sponsored session to be confirmed (Dermatology)
 
 
11:40 AM - 12:25 PM
Glucose patterns and prediabetes: spotting signs early with CGMs

Attendees will be able to:

  • Understand how real time CGM data can reveal early glucose variability that is not captured through traditional testing
  • Recognise the value of CGMs in improving patient awareness, motivation and engagement with dietary change
  • Identify common glucose patterns linked to symptoms such as tiredness, cravings, sleep issues and mood dips
  • Apply CGM insights to guide personalised lifestyle adjustments within primary care
  • Integrate CGMs into existing prediabetes pathways to support early intervention and metabolic risk reduction

This educational session has been sponsored and organised by Abbott and the speaker is presenting on behalf of Abbott. The speaker has received an honorarium for this presentation.  

12:40 PM - 1:25 PM
Supporting mental health in general practice: evidence-based approaches for GPs
 
 
1:40 PM - 2:40 PM
Managing acne in primary care in the era of antimicrobial stewardship
 
 
3:00 PM - 3:45 PM
Lifestyle as treatment: primary care approaches to metabolic and cardiovascular disease
  • Physical activity, nutrition, sleep and stress management
  • Motivational techniques and personalised care plans that work in consultations
  • Achieving sustainable improvements in weight, blood pressure, lipids, and glycaemic control
     
 
3:45 PM
Conference ends
 
 

Speakers